trans-3,4-Difluorocinnamic acid
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
112897-97-9O=C(O)/C=C/c1ccc(F)c(F)c1HXBOHZQZTWAEHJ-DUXPYHPUSA-N112897-97-9DTXSID701347531CHEMBL3397061化学的特性white to light yellow crystal powder
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
使用trans-3,4-Difluorocinnamic Acid is a starting material in the preparation of Ticagrelor (T437700), which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel.